Harnessing the power of artificial intelligence to study plant microbiomes—communities of microbes living in and around ...

In June 2025, Pluri Biotech Ltd., a wholly owned subsidiary of the Company, and a provider of Contract Development and Manufacturing (“CDMO”) services under its PluriCDMO™ business line, entered into ...

New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection.

The most successful players — both old and new — are those focusing on operational risk control rather than assay novelty.

The Cancer Research Institute launches a first-of-its-kind open-access database to help scientists better understand how the immune system responds to cancer treatments over time. The collaborative ...

Congenital heart disease (CHD) is the most common birth defect and a lifelong condition for a growing number of patients ...

At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best set yourself up for success, adapt your approach to the specific scientific ...

Austin, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- As an award–winning company working at the intersection of AI, machine learning, and high-stakes scientific data, Sophelio builds signal-first, ...

Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new ...

Protein scientists could improve reproducibility and coordination across the field by rallying around a small, shared set of "model proteins," according to a new Perspective by Connecticut College ...

The scale-up of rhamnolipid production using waste glycerol was successfully demonstrated under a constant impeller tip speed ...